1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Prevalence of cancer.
4.1.2 Growth in private diagnostic centres.
4.1.3 Development of technological advancements.
4.1.4 Required initiatives to spread awareness about cancer among people.
4.2. Restraints
4.2.1 High cost of diagnostic imaging systems affecting the rate of adoption.
4.2.2 Lack of skilled and experienced professionals.
4.2.3 Risk of radiation exposure.
4.3. Opportunities
4.3.1. Miniaturization and technological advancements.
4.3.2. Personalized medicine.
4.3.3. Development of healthcare infrastructure in emerging markets.
4.4. Challenges
4.4.1. Stringent regulatory guidelines.
4.4.2. Inclination towards the adoption of diagnostic imaging systems.
5. Asia-Pacific Cancer Diagnostics Market - By Type
5.1 Introduction
5.2 Platform based
5.2.1 Polymerase chain reaction
5.2.2 Insitu Hybridization
5.2.3 Immuno Histo Chemistry
5.2.4 Next generation sequencing
5.2.5 DNA microarrays
5.2.6 Flow cytometry
5.2.7 Other technologies
5.3 Instrument based
5.3.1 Imaging
5.3.2 Magnetic resonance Imaging
5.3.3 CT (Computed Tomography)
5.3.4 Positron emission tomography
5.3.4.1 Standalone positron emission tomography
5.3.4.2 Hybrid positron emission tomography
5.3.5 Mammography
5.3.6 Ultrasound
5.3.7 Biopsy
6. Asia-Pacific Cancer Diagnostics Market - By Application
6.1 Introduction
6.1.1 Lung cancer
6.1.2 Breast cancer
6.1.3 Colorectal cancer
6.3.4 Melanoma
6.3.5 Other Cancers
7. Asia-Pacific Cancer Diagnostics Market - By Country
7.1. APAC
7.1.1 China
7.1.2. India
7.1.3. Japan
7.1.3. South Korea
7.1.5. Australia & New Zealand
7.1.6. Rest Of APAC
8. Asia-Pacific Cancer Diagnostics Market - Company Profiles
8.1 Cepheid
8.2 Abbott
8.3 Agilent technologies
8.4 Becton, Dickinson Company
8.5 Roche
8.6 Biomerieux
8.7 Hologic Inc
8.8 Siemen Healthcare
8.9 Qiagen
8.10 Thermo Fisher scientific
8.11 Diadexus
8.12 Epigenomics
9. Asia-Pacific Cancer Diagnostics Market - Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
11. Appendix
11.1. List of tables
11.2. List of figures
